Nano-fiber dressing based on Cardlan polysaccharide and derivative thereof as well as preparation method and application of nano-fiber dressing

The preparation of nanofiber dressings through electrospinning technology of modified polysaccharides and PVA solves the problem of delayed healing in diabetic wounds. By regulating macrophage polarization and improving biological activity, efficient diabetic wound healing and scar reduction are achieved, significantly improving The wound is breathable and antibacterial.

CN118976133APending Publication Date: 2024-11-19SHENYANG PHARMA UNIV
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411068838.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

Diabetic wounds have caused collagen production and immune function imbalances due to the hyperglycemia environment, delayed healing, and existing dressings lack targeted and pro-healing ability, resulting in chronic inflammation and difficult healing problems.

Method used

Modified polysaccharides are miscible with PVA in a certain proportion, and nanofiber dressings are prepared by electrospinning to regulate macrophage polarization, promote diabetic wound healing, and improve biological activity and water dissolution through functionally modified cardlandosaccharide derivatives. , combining PVA's antibacterial and anti-inflammatory properties, creates an efficient healing dressing.

Benefits of technology

It significantly promotes the healing of diabetic wounds, reduces scar formation, improves M2 polarization of macrophages, reduces inflammation, improves the breathability and moisturization of wounds, enhances antibacterial properties, and effectively solves the difficulty of healing and susceptible infection of chronic wounds.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976133A_ABST
    Figure CN118976133A_ABST
Patent Text Reader

Abstract

The invention discloses a nano-fiber dressing based on Cardlan polysaccharide and derivatives thereof and a preparation method and application of the nano-fiber dressing, and belongs to the field of medical materials. Cardlan derivatives (carboxymethyl Cardlan, sulfated Cardlan and aminated Cardlan) which are modified by four different functional groups and have better water solubility are selected, so that the nano-fiber dressing is prepared from the Cardlan polysaccharide, the sulfated Cardlan and the aminated Cardlan. And zinc oxide nano-particles are grafted with carboxymethyl cardelan). The preparation method comprises the following steps: respectively mixing and dissolving cardalan or a derivative thereof with PVA (Polyvinyl Alcohol) in water, and preparing a nanofiber film by utilizing an electrostatic spinning method. The nanofiber dressing is simple in preparation method and component, and medicine loading is facilitated or the nanofiber dressing is directly applied to treatment of various wounds. When the nanofiber dressing is applied to diabetic wounds, chronic diabetic wounds are subjected to induced healing, and the nanofiber dressing can resist inflammation and infection, accelerate wound healing and skin keratinization and reduce hyperplastic scars. The traditional Chinese medicine composition is very effective for treating wounds and skin injuries of diabetic patients. The wound dressing can be used for healing chronic wounds, especially diabetic wounds.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of medical materials, and specifically relates to an electrospun nanofiber dressing composed of polysaccharide polymer and PVA material, and a preparation method and application thereof. The nanofiber dressing can regulate macrophage polarization and significantly promote the healing of diabetic wounds. Background Art

[0002] Diabetes is an increasingly common disease, and diabetic ulcers are one of the most common complications. Due to the high blood sugar wound environment of diabetic patients, collagen production and immune function balance in the wound site are seriously affected. Therefore, the transition of wound healing from the inflammatory stage to the proliferation stage is delayed, causing diabetic wounds to transform from ordinary wounds to chronic wounds that are difficult to heal. The treatment of diabetic wounds often requires high costs, and severe cases may even lead to amputation. Many studies have shown that the ability to regulate macrophage polarization toward the anti-inflammatory, pro-healing M2 type is beneficial to the resolution of chronic inflammation in diabetic wounds, thereby promoting wound healing. However, there are currently no commercially available wound dressings for immune regulation.

[0003] Polysaccharide polymers are natural polymer materials with good biocompatibility, biodegradability, and easy modification. Some materials also have immunomodulatory functions. Curdlan is a β-1,3-glucan that is widely used in food additives due to its excellent biocompatibility and modifiability, but its biological activity and drug applications are very limited due to its poor hydrophilicity. Curdlan polysaccharide is now functionally modified to improve its biological activity and water solubility. The modified polysaccharide can be miscible with PVA in a certain proportion and electrospun into nanofibers.

[0004] Compared with traditional dressings, polysaccharide composite nanofiber dressings have good water absorption and air permeability, and can maintain the wound in a moist environment suitable for wound healing. It is also antibacterial and anti-inflammatory, and can significantly promote wound healing and skin keratinization, and is very effective in treating wounds and skin injuries in diabetic patients. Summary of the invention

[0005] The purpose of the present invention is to provide a polysaccharide composite nanofiber dressing, a preparation method and an application. The method mixes polysaccharides or their derivatives with PVA, and electrospins to obtain a composite nanofiber film with anti-inflammatory properties, promotes directional polarization of macrophages, and promotes the healing of chronic wounds such as diabetes. In the study, a type II diabetic wound model was established, and local administration of the wound was performed. Except for the amino-curdlan composite nanofiber dressing, the other dressings showed the ability to promote wound healing and reduced scar hyperplasia. The present invention overcomes the problems that existing wound dressings lack specificity for chronic wounds such as diabetic wounds and have poor healing ability. In vitro, each composite dressing (except amino-curdlan) showed the ability to promote the proliferation and migration of fibroblasts and glial cells. In addition, it can also promote the polarization of macrophages to M2 type. In vivo, the application of composite nanofibers promoted a significant increase in M2 macrophages with anti-inflammatory and healing functions, and a decrease in inflammatory M1 macrophages, which promoted the disappearance of chronic inflammation, thereby significantly promoting the healing of diabetic wounds. At the same time, compared with the positive control commercially available calcium alginate nanofiber dressing preparation, it can effectively prevent the generation of hypertrophic scars while having a comparable healing ability. The present invention evaluates the credibility of the polysaccharide composite nanofiber dressing in regulating immune function and promoting diabetic wound healing.

[0006] Specifically, the purpose of the present invention is to provide a polysaccharide composite nanofiber dressing with immunomodulatory function, reduce wound inflammation, and promote wound healing, in response to chronic inflammation of diabetic wounds that leads to slow healing or even non-healing, which further leads to problems such as difficulty in wound care and susceptibility to infection, as well as study of its activity in regulating macrophage polarization in the application of the dressing in the treatment of diabetic wounds.

[0007] In order to reduce chronic inflammation and regulate the polarization of macrophages to promote healing, the present invention selects β-1,3-glucan with immunomodulatory function: Curdlan polysaccharide (CU).

[0008] In order to solve the problem of poor solubility of curdlan polysaccharide and its poor biological activity, the present invention prepares several functionally modified curdlan polysaccharide derivatives: carboxymethyl curdlan (CMC), sulfonated curdlan (SC), amino curdlan (AC), zinc oxide-carboxymethyl curdlan (ZnO-CMC). Except ZnO-CMC, the synthesis of other derivatives uses the existing synthesis method. The steps of the ZnO-CMC synthesis process are as follows:

[0009] CMC was added to 0.02M zinc sulfate aqueous solution and stirred until dissolved. 0.04M NaOH aqueous solution was slowly added dropwise under vigorous stirring at room temperature, and the temperature was raised to 90°C and stirred vigorously for 1h. After the reaction was completed, acetone was poured into the solution, washed 3 times, filtered, and the precipitate was dried at 90°C.

[0010] In order to solve the problem of poor spinnability of curdlan polysaccharide and its derivatives, the present invention mixes curdlan polysaccharide and its derivatives with PVA at a mass ratio of 1:4, and then performs electrostatic spinning to obtain a nanofiber dressing. The fiber filaments in the nanofiber dressing are randomly arranged, and the nanometer diameter is 120-220nm. The maximum tensile strength of the nanofiber dressing is 3.5-5.5MPa, and the Young's modulus is 1-2MPa. Specifically: polysaccharide composite nanofibers are prepared by a blending method, and the process parameters of the preparation are investigated by a single factor analysis method: the mass ratio of curdlan polysaccharide and its derivatives to PVA, the concentration of PVA, the temperature and humidity of spinning, the voltage and the spinning rate. By observing the diameter and morphology of the nanofibers, the optimal preparation method is optimized.

[0011] The optimal preparation method comprises the following steps:

[0012] 400 mg of Curdlan polysaccharide and its derivatives and 1.6 g of PVA were dissolved in 20 ml of distilled water, stirred and dissolved at room temperature for 12 hours to obtain a uniform aqueous solution. The mixed solution was filled into a 20 ml syringe for spinning. Further, after the spinning was completed, the composite nanofiber dressing was collected and vacuum dried for 72 hours to remove the residual solvent. The spinning speed was 0.1 ml / h, the voltage was 23 kV, the distance from the collector (spinning distance) was 15 cm, the collector drum speed was 100 rpm, the spinning temperature was 25 ± 5 ° C, and the spinning humidity was 40 ± 10% RH. The dosage ratio of Curdlan polysaccharide and its derivatives, PVA, and distilled water was: 0.4 g: 1.6 g: 20 ml.

[0013] In order to investigate the credibility of the composite nanofiber membrane in promoting diabetic wound healing by promoting macrophage polarization toward M2, pure PVA nanofiber films were also prepared and various films were evaluated in vitro and in vivo. The detailed investigation contents are as follows:

[0014] (1) Curdlan polysaccharide and different Curdlan polysaccharide derivatives were characterized, such as 1 H NMR, 13 C NMR, FT-IR, DSC, XRD and SEM, etc.

[0015] (2) The physical properties of various membranes were investigated, such as nanofiber morphology, size, mechanical properties of nanofibers, and air permeability.

[0016] (3) The cytotoxicity of various membrane extracts on 3T3 cells, Hacat cells, and Raw264.7 cells was investigated.

[0017] (4) The ability of various membrane extracts to promote the migration of 3T3 cells and Hacat cells was investigated.

[0018] (5) The ability of various membrane extracts to promote the polarization of Raw264.7 cells to M2 type was investigated.

[0019] (6) The regulatory effects of various membrane extracts on macrophage polarization and their effects on promoting diabetic wound healing in vivo were investigated.

[0020] The results show that the composite nanofibers of various curdlan polysaccharides and their derivatives (except AC composite nanofiber membranes) prepared by the present invention have a significant promoting effect on diabetic wound healing and promote macrophage polarization to M2 type, and can be used for the healing of chronic wounds, especially diabetic wounds.

[0021] Beneficial effects of the present invention:

[0022] The present invention selects four different functional group modified, better water-soluble curdlan derivatives (carboxymethyl curdlan, sulfonated curdlan and aminated curdlan, zinc oxide nanoparticles grafted carboxymethyl curdlan). Curdlan or its derivatives are respectively mixed with PVA in water, and a nanofiber film is prepared by an electrostatic spinning method. The preparation method and composition of the nanofiber dressing are simple, and it is convenient to load drugs or directly apply to various types of wound treatment. Among them, except for the aminated curdlan dressing, the other dressings are used in diabetic wounds to induce healing of diabetic chronic wounds, can resist inflammation and infection, accelerate wound healing and skin keratinization, and reduce hypertrophic scars. It is very effective for treating wounds and skin injuries in diabetic patients. Among them, carboxymethyl curdlan and sulfonated curdlan dressings can promote the polarization of macrophages to M2, promote the disappearance of inflammation in the wound site, solve the long-term inflammation problem of chronic wounds, and accelerate the healing rate of chronic wounds. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 The process of synthesizing each derivative.

[0024] Figure 2 The H NMR spectra of the synthesis results. A is the H NMR spectrum of CU, the solvent is deuterium oxide; B is the H NMR spectrum of AC, the solvent is deuterium oxide; C is the H NMR spectrum of CMC, the solvent is deuterium oxide; D is the H NMR spectrum of CMC-ZnO, the solvent is deuterium oxide; E is the H NMR spectrum of SC, the solvent is deuterium oxide.

[0025] Figure 3 This is the carbon NMR spectrum of the synthesis results.

[0026] Figure 4 This is the infrared spectrum of the synthesis result.

[0027] Figure 5The scanning electron microscope and element energy scanning diagram of CMC-ZnO. A is the scanning electron microscope diagram of CMC-ZnO; B is the element energy scanning diagram of CMC-ZnO; C is the element distribution diagram of C element; D is the element distribution diagram of O element; E is the element distribution diagram of Zn element.

[0028] Figure 6 A is the thermodynamic properties of the synthesized product. B is the DSC result of the synthesized product. C is the XRD result of the synthesized product.

[0029] Figure 7 Figure 1 is a photo and a scanning electron microscope image of the nanofiber membrane. Figure 2 is a photo of the spinning solution and membrane preparation of each nanofiber membrane; Figure 3 is a scanning electron microscope image of each nanofiber membrane and a statistical distribution image of the fiber diameter.

[0030] Figure 8 The mechanical properties of the nanofiber membranes are investigated. A is the tensile strength of each nanofiber membrane; B is the tensile fracture rate of each nanofiber membrane; C is the maximum tensile strength of each nanofiber membrane; and D is the Young's modulus of each nanofiber membrane.

[0031] Fig. 9 The water vapor permeability diagram of each nanofiber membrane.

[0032] Fig.10 The contact angle diagram of each nanofiber membrane.

[0033] Fig.11 The cytotoxicity and cell migration rate of each synthetic material are investigated. A is the statistical result of the cytotoxicity of each synthetic material on 3T3 cells, Hacat, and Raw264.7; B is the result of the effect of each synthetic material on 3T3 cell migration; C is the quantitative graph of B; D is the result of the effect of the synthetic material on Hacat migration; E is the quantitative graph of D.

[0034] Fig.12 The cytotoxicity and cell migration rate of each nanofiber dressing were investigated. A is the statistical result of the cytotoxicity of each nanofiber dressing on 3T3 cells, Hacat, and Raw264.7; B is the result of the effect of each nanofiber dressing on 3T3 cell migration; C is the quantitative graph of B; D is the result of the effect of each nanofiber dressing on Hacta migration; E is the quantitative graph of D.

[0035] Fig.13 The effects of various nanofiber dressings on macrophage polarization were investigated. A is the flow cytometry results of the effects of various nanofiber dressings on macrophage polarization; B is the quantification of M1 macrophages in A; C is the quantification of M2 macrophages in A.

[0036] Fig.14This is an investigation of the ability of nanofiber dressings to promote wound closure in type 2 diabetic mice. A is the animal experiment flow chart; B is a photo of the mouse wound and a fitting diagram; C is a quantitative diagram of mouse wound closure; D is the weight change of the mouse during the administration period.

[0037] Fig.15 This is an investigation of the ability of nanofiber dressings to promote wound healing in type 2 diabetic mice. A is the H&E staining result of the skin tissue at the wound site; B is the result of epithelialization; C is the quantitative scar hyperplasia index; D is the Masson staining result of the skin tissue at the wound site.

[0038] Fig.16 This is an investigation of the effect of nanofiber dressings on promoting blood vessel growth in wounds of type 2 diabetic mice. A is a staining image of CD31 and α-SMA in the wound site; B is a quantitative image of immature blood vessels; C is a quantitative image of mature blood vessels.

[0039] Fig.17 This is an investigation of the effect of nanofiber dressings on macrophage polarization in wounds. A is the immunohistochemistry result of wound skin tissue; B is the quantification result of M1 macrophages; C is the quantification result of M2 macrophages.

[0040] Fig.18 This is the result of flow cytometry of macrophage phenotype in the wound site on the 14th day. DETAILED DESCRIPTION

[0041] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples.

[0042] Embodiment 1:

[0043] The synthesis method and characterization of the cadran polysaccharide derivatives, the synthesis process is shown in Figure 1 , including the following steps:

[0044] SC Synthesis:

[0045] Weigh 1.0g CU and 4.0g pyridinium sulfonate into a dry round-bottom flask, add 30ml DMSO, and stir to dissolve. Heat to 65°C and stir to react for 1h. After the reaction is completed, precipitate the product with excess sodium acetate methanol solution (5wt%) and wash 3 times. After filtering, redissolve in water, dialyze for 48h, and freeze-dry to obtain the product SC.

[0046] AC Synthesis:

[0047] 1.0g CU and 9.0g LiBr were weighed into a dry round-bottom flask, 40ml DMAc was added, and the mixture was stirred at 165°C for 26min under nitrogen protection. After the reaction, the solution was cooled to room temperature, 6.49g triphenylphosphine and 4.40g N-bromosuccinimide were weighed, and the reaction was continued for 24h under normal temperature stirring. After the reaction, the product was precipitated with excess methanol / water (1:1, v / v), washed 3 times, filtered and dried in vacuum at 40°C to obtain the product 6-bromo-6-deoxycadran.

[0048] Weigh 1.0g of 6-bromo-6-deoxycadherin and 1.45g of sodium azide in a dry round-bottom flask, add 100ml of DMSO, and react at 80°C for 24h under nitrogen protection. After the reaction is completed, cool to room temperature, add excess pure water to precipitate the product, wash it with excess acetone 3 times, and freeze-dry to obtain the product 6-azido-6-deoxycadherin.

[0049] Weigh 1.0g of 6-azido-6-deoxycadran and 5.4g of sodium borohydride into a dry flask, add 100ml of DMSO, and react at 100℃ for 24h under nitrogen protection. After the reaction, the reaction solution is cooled to 0℃, 1.0M HCl is added dropwise until no gas is generated, neutralized with NaHCO3 solution, and then dialyzed with distilled water for 48h. After freeze-drying, the product AC is obtained.

[0050] CMC Synthesis:

[0051] Weigh 1.0g CU in a dry round-bottom flask, add 30ml isopropanol, and stir to dissolve for 30min. Slowly add 3ml sodium hydroxide solution (30wt%) under stirring, and continue to react for 90min. Add 1.2g chloroacetic acid, heat to 55℃, and continue to react for 5h under stirring. After the reaction is completed, rinse with formic acid / acetic acid (7:3, v / v), methanol / water (4:1, v / v) and acetonitrile in sequence, filter and redissolve in water, dialyze with distilled water for 48h, and freeze-dry to obtain the product CMC.

[0052] CMC-ZnO Synthesis:

[0053] Weigh 1.0g CMC into a dry round-bottom flask, add 5ml zinc sulfate aqueous solution (0.02M), and stir to dissolve at room temperature. Under stirring, add 5ml NaOH solution (0.04M), heat to 90℃, and stir to react for 1h. After the reaction is completed, add excess acetone to precipitate the product, wash 3 times, filter, and dry in a vacuum oven at 90℃ overnight to obtain the product CMC-ZnO.

[0054] We next analyze the original CU and its derivatives 1 H NMR (600 MHZ) was compared. Figure 2 As shown, natural CU shows that the sugar ring protons resonate between δ3.9-3.6ppm. In the AC spectrum, the signal of the amino proton (-NH2) appears at δ8.5ppm, suggesting that AC is successfully synthesized. In the CM spectrum, the carboxylic acid (-COOH) signal appears at δ4.3ppm, suggesting that CMC is successfully synthesized. In the SC spectrum, the proton signal of C6 and the hydroxyl proton (-OH) signal of C2 move to δ4.3ppm and δ4.4ppm, respectively, indicating that some changes have occurred in C6 or C4 of the glucose unit.

[0055] Figure 3 As shown, natural CU and its derivatives 13 C NMR (600MHZ) spectrum. In the spectrum of SC, the C6 chemical shift signal moved from 61.3ppm and 62.4ppm to 68.0ppm, and the signal of (C4) moved from about 68.5ppm to 69.0ppm, indicating that the hydroxyl group at C6 was sulfated. The signal of C2 moved from 73.2ppm to 75.6ppm, indicating that some hydroxyl groups on C2 were sulfated. In the AC spectrum, the C6 signal dropped from 61.3ppm to 41.5ppm, and the hydroxyl group on the surface C6 was replaced by amino group. In the spectrum of CMC, the C6 signal at 61.3ppm in natural CU moved to 70.2ppm, and the C2 signal moved from 73.2ppm to 74.3ppm, indicating that the hydroxyl groups of the glucose units on C2 and C6 were replaced. A new shift signal appeared at 177.8ppm, which was attributed to the methylene C7 on the carboxymethyl group.

[0056] Figure 4 The following are the FT-IR spectra of natural CU and its derivatives. AC is at 1575 cm -1 A new characteristic absorption peak is shown at 1200 cm-1, which is attributed to the bending vibration peak of NH. -1 and 819cm -1 There are two characteristic peaks, namely the asymmetric stretching vibration of S=O and the symmetric stretching vibration of COS. -1 and 1421cm -1 There are two characteristic peaks at 1076 cm -1 The enhanced peak at 3295cm is attributed to the asymmetric stretching vibration of Zn-O-Zn. -1 The intensity of the hydroxyl band at is weakened, but the width increases, which is attributed to the reaction between the carboxylic acid groups of CMC and ZnO to form zinc carboxylate.

[0057] To further characterize the morphological appearance of CMC-ZnO, we observed the morphology and element distribution of CMC-ZnO by scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDS). Figure 5 As shown, the scanning electron microscope image shows that the CMC-ZnO nanoparticle composite material is irregular in shape, but relatively uniform. The typical absorption of metallic zinc is about a strong signal of 1keV and two weak signals of 8.5keV. The elemental map shows that the zinc element is uniformly distributed in the CMC-ZnO composite material. The local relative concentration of the C element is high, indicating that CMC forms a nanocomposite material as a capping agent for ZnO nanoparticles.

[0058] The physical properties of CU and its derivatives were further studied. Figure 6 The following are the results of TGA, DSC and XRD of CU and its derivatives. In the DSC curve, there is a broad internal thermal peak at around 100°C, which corresponds to the loss of water in the sample skeleton. The decrease of this internal thermal peak indicates that the conjugated groups on the curled carbon chain reduce the water holding capacity of the polysaccharide. The decomposition temperature of SC is lower than that of natural CU and other derivatives, which may be related to the reduction of intermolecular hydrogen bonds. This result is consistent with the TGA analysis, indicating that the thermal stability of SC is lower than that of natural CU and other derivatives. Figure 6 As shown in Figure C, natural CU and its derivatives are typical amorphous substances with a peak at 2θ = ~20°, which usually appears in amorphous natural polysaccharides.

[0059] Embodiment 2:

[0060] Preparation and characterization of various polysaccharide composite nanofiber dressings based on PVA (PVA / CU, PVA / AC, PVA / SC, PVA / CMC and PVA / CMC-ZnO):

[0061] Preparation method: Different polysaccharides and their derivatives (CU, AC, SC, CMC and CMC-ZnO) were first dissolved in distilled water, and then PVA (1:4, w / w) was added and stirred at room temperature for 12 h to obtain a uniform spinning solution. Figure 7 A. The solution was injected into a 20 ml syringe and then installed on an electrospinning machine, operating at a high voltage of 23 kV. The injection rate was 0.1 ml / h. The distance from the needle tip to the roller collector was fixed at 15 cm, and the roller collector speed was 100 rpm. The electrospinning process was carried out under controlled environmental conditions (25 ± 5 ° C and 40 ± 10% relative humidity). After collecting the composite nanofiber dressing, it was vacuum dried for 72 h to remove the residual solvent. The manufacturing method of pure PVA nanofiber dressing was similar to this, without the incorporation of any polysaccharide.

[0062] like Figure 7As shown, the appearance of each nanofiber dressing obtained is uniform and flat. Scanning electron microscope images show that the fibers in pure PVA nanofiber dressings, PVA / CU, PVA / AC, and PVA / CMC composite nanofiber dressings are all smooth in surface, uniform in diameter, and without beading adhesion. However, there are some beads in the PVA / SC nanofiber dressing, and some fiber adhesions in the PVA / CMC-ZnO nanofiber dressing. Statistical results show that the average fiber diameter of pure PVA nanofiber dressings is 150±30nm, while the diameter of polysaccharide composite nanofiber dressings varies, ranging from 112-221nm. It can be seen that each composite dressing is a porous nanofiber dressing constructed of uniform nanoscale fibers of about 100-200nm.

[0063] Example 3: Investigation of the physical and chemical properties of composite nanofiber dressings:

[0064] like Figure 8 As shown in the figure, different composite nanofiber dressings exhibited very different mechanical properties compared with pure PVA nanofiber dressings. Pure PVA dressings are soft and elastic, with elongation, strength and Young's modulus of 27.11±4.93%, 3.82±1.37MPa, and 1.18±0.34MPa, respectively. Compared with PVA nanofiber dressings, most composite nanofiber excipients containing CU or its derivatives had lower elongation and higher Young's modulus values. The tensile length of PVA / CU nanofiber dressings increased, while that of composite nanofiber dressings of other derivatives decreased. However, the mechanical strength of all nanofiber dressings is sufficient to prevent tearing during handling and can be used on diabetic wound surfaces.

[0065] Fig. 9 The water vapor permeability of different nanofiber dressings is shown. The water vapor permeability of all nanofiber dressings is between 2942±481 and 3959±1109 ​​g / m 2 · Day by day, it is close to the ideal value for wound dressing, which is beneficial to maintain the water-vapor balance in the wound area.

[0066] The wettability of composite nanofiber dressings of CU and its derivatives was evaluated, and the water contact angles of various composite nanofiber dressings over time were recorded. Fig.10 As shown. Although the wettability of the composite dressings was affected by various modified curdlan derivatives, a water droplet was still able to spread along the surface of the composite nanofibrous dressing to a water contact angle of nearly 0° within 10 seconds. All dressings have excellent wettability because they are mainly composed of PVA, which is a hydrophilic polymer itself. The excellent wettability of the composite nanofibrous dressings is beneficial to the adhesion, proliferation and migration of cells during wound healing. In addition, improving surface wettability can also enhance the anti-inflammatory response of macrophages.

[0067] Embodiment 4:

[0068] Study on the in vitro cytotoxicity and cell migration promoting ability of polysaccharide composite nanofiber dressing:

[0069] In order to evaluate the cytotoxicity of CU and its derivatives and composite nanofiber membranes, we used CCK-8 method to investigate the cytotoxicity of mouse NIH 3T3 cells, human immortalized keratinocytes (Hacat) cells, and mouse macrophages (RAW264.7) cells. The migration ability of 3T3 cells and Hacat cells was detected by scratch method.

[0070] like Fig.11 As shown in the figure, at a concentration of 10 μg / ml, natural CU, SC, CMC and CMC-ZnO had no obvious cytotoxicity to 3T3 cells, Hacat cells and RAW 264.7 cells, and SC and CMC showed a strong promoting effect on the proliferation of 3T3 cells. AC showed a significant inhibitory effect on the proliferation of the three cells, which was related to the positive charge of AC. Fig.11 As shown in B and 11C, AC showed a strong inhibitory effect on 3T3 cell migration, which was consistent with the cytotoxicity experiment. Natural CU and CMC showed a promoting effect on 3T3 migration, while other materials had no significant effect on 3T3 migration. Fig.11 As shown in D and 11E, AC also inhibited the migration of Hacat cells. CMC-ZnO showed a significant promoting effect on Hacat.

[0071] Fig.12 A shows the results of cell viability tests on 3T3 cells, Hacat cells and Raw 264.7 using various composite nanofiber dissolutions containing the same polysaccharide concentration (10 μg / ml). Compared with PVA nanofiber dressings, CU and its derivative composite nanofiber dressings had no obvious toxicity to fibroblasts, keratinocytes and macrophages, but only PVA / AC composite nanofiber dressings had a significant inhibitory effect on the proliferation of these three cells. These trends are consistent with the results of various polysaccharide solution investigations. These findings show that CU and its derivatives have different cell activities on different cells. In addition, it was observed that PVA / SC, PVA / CMC, and PVA / CMC-ZnO composite nanofiber dressings were more compatible with different cell lines. Fig.12B, 12C showed that PVA / SC composite nanofiber dressings were significantly more effective than nanofiber dressings containing other CU and its derivatives in promoting fibroblast migration. However, the PVA / AC nanofiber dressing group significantly inhibited the migration of fibroblasts, which was related to its cytotoxicity to fibroblasts. In addition, PVA / CMC and PVA / CMC-ZnO also promoted the migration of fibroblasts to a certain extent. When the composite nanofiber dressings of CU and its various derivatives were used on keratinocytes ( Fig.12 D, 12E), PVA / CMC and PVA / CMC-ZnO composite nanofiber dressings have the greatest promoting effect, and the migration rate reaches 27% compared with the nanofiber dressings composited with CU or other derivatives. Compared with the PVA nanofiber dressing control group, other derivatives except PVA / AC composite nanofiber dressings also promote the migration of keratinocytes.

[0072] Embodiment 5:

[0073] Study on the effect of polysaccharide composite nanofiber dressing on promoting macrophage polarization in vitro:

[0074] In order to evaluate the ability of various nanofiber dressings to affect macrophage polarization, we conducted a polarization study on the RAW 264.7 cell line. RAW264.7 macrophages were treated with various composite nanofiber dissolutions containing the same polysaccharide concentration (10 μg / ml) for 48 h. For the polarization of M2 macrophages, IL-4 was used as a positive control group, and for the polarization of M1 macrophages, lipopolysaccharide (LPS) was used. Flow cytometry was used for quantitative analysis. Fig.13 As shown in the figure, compared with pure PVA nanofiber membrane, PVA / AV composite nanofiber membrane significantly increased the M1 type (CD86 + ) macrophages, while PVA / SC and PVA / CMC promoted the M2 type (CD206 + ) macrophages, while PVA / CMC-ZnO increased the proportion of M1 and M2 macrophages at the same time. The study found that CU had a slight activation effect on macrophages, and SC, AC and CMC had stronger immunostimulatory effects than insoluble curdlan. M1 polarization was observed in AC-treated macrophages. This may be due to the activation of Toll-like receptor 4 by positively charged AC and the expression of co-stimulatory molecules CD80 and CD86. CMC can promote macrophage polarization to M2, which may be due to the fact that the hydroxyl and carboxyl groups in the polymer chain can easily absorb hydrogen atoms in free radicals to form stable polymer groups, thereby resisting oxidative stress and reducing the release of inflammatory factors, thereby creating a microenvironment conducive to the development of M2 macrophages. CMC-ZnO stimulated both M1 and M2 polarization, which is due to the biphasic effect of ZnO NPs in the regulation of inflammation at different pathological stages.

[0075] Embodiment 6:

[0076] Investigation of the ability of polysaccharide composite nanofiber dressing to promote diabetic wound healing:

[0077] In order to evaluate the ability of polysaccharide composite nanofiber dressings to promote diabetic wound healing, we established a chronic diabetic wound mouse model. Fig.14 A: First, C57 mice were fed a high-fat diet for 28 days to induce insulin resistance. The mice were injected with 60 mg / kg streptozotocin for three consecutive days to induce type II diabetes (insulin-dependent). The mice maintained high blood sugar levels (≥16.7 mmol / L) for one week, and then a full-thickness skin wound with a diameter of 8 mm was made on their backs as a diabetic wound model. Polysaccharide fiber dressing served as the positive control group.

[0078] The wound healing process was recorded by taking photos. Fig.14 B: After 14 days of treatment, PVA / CMC, PVA / CMC-ZnO composite nanofibers and Wounds treated with 100% chloramphenicol dressings showed more significant improvement than wounds treated with other dressings or untreated wounds. Wound closure was quantified as a function of time. Fig.14 C, PVA / AC nanofiber dressings significantly hindered wound healing on days 7 and 14, which may be due to the inhibitory activity of PVA / AC ENDs on fibroblast proliferation. The positive control group showed an effect of promoting wound healing within 10 days. After 14 days of treatment, although the wounds of each group were basically healed, the PVA / SC, PVA / CMC, PVA / CMC-ZnO composite nanofiber dressings and The healing effect was better. During the experiment, there was no significant difference in the body weight of all animal groups ( Fig.14 D), indicating that the mice were in good health.

[0079] To further evaluate the wound healing efficiency, H&E staining of wound sections on days 7 and 10 was further analyzed. Fig.15A. After 7 days of treatment, the granulation tissues of all groups showed high local inflammation characterized by infiltration of neutrophils and macrophages. However, the epidermis of all nanofiber dressing-treated groups, except for the PVA / AC composite nanofiber dressing, began to crawl (solid black line). After 14 days of treatment, the inflammatory response of the PVA / CMC and PVA / CMC-ZnO composite nanofiber dressings was alleviated, while the pure PVA dressing, PVA / AC, PVA / SC composite nanofiber dressing treatment groups and the control group still showed severe inflammation. The persistent inflammation in the PVA / AC group is consistent with the results of in vitro studies, which showed that PVA / AC can induce macrophage M1 polarization. The wounds treated with the different nanofiber dressings were significantly better than those treated with the other groups. The epithelial cell growth rates of the corresponding groups were analyzed after treatment with the different nanofiber dressings. Fig.15 B). On the 7th day of treatment, the PVA / CMC composite nanofiber dressing group (54.9%), PVA / CMC-ZnO composite nanofiber dressing group (51.4%), PVA / SC composite nanofiber dressing group (47.2%) and The epidermal crawling speed of the PVA / CMC and PVA / CMC-ZnO composite nanofiber dressings was faster than that of the control group and other composite nanofiber dressing groups (p<0.05). These findings are consistent with the results of in vitro migration assessment, that is, PVA / CMC and PVA / CMC-ZnO composite nanofiber dressings can promote the migration of keratinocytes. Scar hyperplasia index was further used for tissue morphology analysis ( Fig.15 C). If the value is greater than 1.0, it indicates the formation of hypertrophic scars. Compared with the control group, the scar hyperplasia index values ​​of the PVA / CMC and PVA / CMC-ZnO composite nanofiber groups were closer to normal skin, indicating that they were effective in preventing excessive scar formation.

[0080] To further evaluate the role of various nanofiber dressings in wound healing, we analyzed the deposition of collagen in the wound by Masson trichrome staining ( Fig.15 D). After 14 days of treatment, PVA / CU, PVA / CMC, PVA / CMC-ZnO composite nanofiber dressings and The treated group showed more mature collagen than the other composite groups and the control group. This finding is consistent with the results of in vitro cell tests, which showed that PVA / CU, PVA / CMC, and PVA / CMC-ZnO composite nanofiber dressings significantly increased the proliferation of fibroblasts. Since fibroblasts can synthesize and secrete collagen, these composite nanofiber dressings have a significant promoting effect on the deposition and maturation of collagen in the wound.

[0081] Double immunofluorescence staining of CD31 and α-SMA was used to evaluate the angiogenesis of wound tissues in each group after 14 days of treatment ( Fig.16 ). CD31 is an important indicator of angiogenesis, while α-SMA is an indicator of mature blood vessels. The results showed that the density and number of blood vessels in the composite nanofiber treatment group were higher than those in the control group ( Fig.16 In addition, the vascular maturity was higher in the PVA / CMC, PVA / CMC-ZnO composite nanofiber dressings, and positive groups compared with the other dressing treatment groups ( Fig.16 ). During the remodeling phase of wound healing, the maturation of the vascular network is essential for the reconstruction of the wound tissue microenvironment. Overall, the CMC / PVA and SC / PVA composite nanofibrous dressings were superior to the composite nanofibrous dressings of Cadlan and other derivatives in terms of angiogenesis.

[0082] Embodiment 7:

[0083] Study on the effect of polysaccharide composite nanofiber dressing on promoting macrophage polarization in vivo:

[0084] We sliced ​​and immunofluorescently stained wound tissues on the 14th day after treatment to investigate whether topical application of composite nanofiber dressings to wounds would affect the polarization of macrophages ( Fig.17 We selected iNOS and ARG as M1 and M2 macrophage markers, respectively. After 14 days of treatment with PVA / CU and PVA / CMC composite nanofiber dressings, the expression of iNOS was significantly decreased, while the expression was higher in the PVA / AC composite nanofiber dressing treatment group and the control group ( Fig.17 ). This indicates that the factors produced by M1 macrophages have pro-inflammatory and extracellular matrix-degrading properties. However, the expression of ARG-1 in the PVA / SC, PVA / CMC, and PVA / CMC-ZnO composite nanofiber-treated groups was higher than that in the control group, which confirmed that M2 macrophages were activated to a large extent.

[0085] To further investigate the potential effects of different nanofiber dressings on the phenotypic transition of macrophages in wound tissue after 7 days of treatment, we performed flow cytometry analysis ( Fig.18 ). After being treated with various composite nanofibers of Kadlan and its derivatives, F4 / 80 + / CD80 + Compared with the control group and pure PVA nanofiber dressings, the composite nanofiber dressings of Kadlan and its derivatives (AC, CS, CMC) and positive F4 / 80 of the group + / CD206 + The number of macrophages (M2 type) increased significantly. Among all composite nanofiber dressings, the M2 polarization of PVA / CMC composite nanofiber dressings in wound tissue was the most obvious. These research results show that for chronic diabetic wounds, PVA / CMC composite nanofiber dressings can reduce the inflammatory response in the early stage of wound healing and promote the transformation of macrophages from the pro-inflammatory M1 phenotype to the repair M2 phenotype, thereby accelerating the transition of wounds from the inflammatory stage to the proliferation stage and enhancing the healing effect.

Claims

1. A nanofiber dressing based on curdlan polysaccharide and its derivatives, characterized in that: The nanofiber dressing is a composite of PVA and polysaccharide or its derivatives, and is obtained by blending through an electrostatic spinning method, and the average diameter of the fiber filaments is between 120-220nm.

2. The nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 1, characterized in that: The polysaccharide is curdlan polysaccharide, and the polysaccharide derivatives include carboxymethyl curdlan, sulfonated curdlan, amino curdlan and zinc oxide-carboxymethyl curdlan.

3. The nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 1, characterized in that: The maximum tensile strength of the nanofiber dressing is 3.5-5.5 MPa, and the Young's modulus is 1-2 MPa.

4. The method for preparing the nanofiber dressing based on Curdlan polysaccharide and its derivatives according to any one of claims 1 to 3, characterized in that: include: The polysaccharide or its derivative is co-dissolved with PVA in distilled water at room temperature to obtain a spinning solution, which is then electrospun to obtain a nanofiber dressing.

5. The method for preparing the nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 4, characterized in that: Dissolve the polysaccharide or its derivative in distilled water, stir for 1-2 hours, add PVA, and continue stirring.

6. The method for preparing the nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 4, characterized in that: The dosage ratio of the polysaccharide or its derivative, PVA and distilled water is: 0.4g:1.6g:20ml.

7. The method for preparing the nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 4, characterized in that: The voltage of the electrospinning was 23 kV, the spinning speed was 0.1 mL / h, the spinning distance was 15 cm, the rotating speed of the collector drum was 100 rpm, and the spinning environmental conditions were: 25±5° C. temperature and 40±10% relative humidity.

8. The method for preparing the nanofiber dressing based on curdlan polysaccharide and its derivatives according to claim 4, characterized in that: After spinning, the composite nanofiber dressing was collected and vacuum dried for 72 h to remove the residual solvent.

9. Use of the nanofiber dressing based on curdlan polysaccharide and its derivatives according to any one of claims 1 to 3 in the preparation of medicines or medical materials for the healing of chronic wounds.

10. Use of the nanofiber dressing based on curdlan polysaccharide and its derivatives according to any one of claims 1 to 3 in the preparation of medicines or medical materials for healing diabetic wounds.

Citation Information

Cited By

  • Electrostatic spinning membrane biological material and anti-inflammatory activity application thereof

    CN119236148A

  • An electrospinning membrane biomaterial and its anti-inflammatory activity application

    CN119236148B